REG - Camellia PLC - Director Changes

CamelliaAnnouncement

17/07/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230717:nRSQ1447Ga&default-theme=true

RNS Number : 1447G  Camellia PLC  17 July 2023

17(th) July 2023

 

Camellia Plc

(the "Company")

 

Director changes

 

Camellia Plc is pleased to announce the appointment of Byron Coombs as a
director and Chief Executive Officer with effect from 25(th) September 2023.

 

Byron has extensive experience in the financial and investment management
sectors and served as Chief Executive Officer of the Group's private bank,
Duncan Lawrie, from 2014 until its sale in 2017, since when Byron has been
employed by the Group as Investment Director.  Byron is also a Non-executive
Director of Julius Baer International Limited, from which position he will
resign on 31(st) December 2023.  He has previous non-executive and executive
experience at Deutsche Bank UK, RBS Wealth Management, Citibank Private Bank,
and Merrill Lynch Debt Markets. Byron's appointment follows an extensive
candidate search.

 

Camellia's Chairman, Malcolm Perkins, who has also acted as Interim Chief
Executive Officer since 1(st) July 2022, will continue as Interim Chief
Executive until Byron Coombs' appointment in September.  Malcolm will retire
on 30(th) November 2023 following 51 years' service in the Group.  Malcolm
has provided outstanding leadership throughout the years; the Company thanks
him for his loyalty, contribution and commitment, and wishes him all the very
best in his retirement.

 

Simon Turner, currently a Non-executive Director of the Company, will become
Non-executive Chairman upon the retirement of Malcolm Perkins.  Simon will
resign from his position as director of the Camellia Private Trust Company
(the trustee of The Camellia Foundation (Bermuda)) and director of Camellia
Holding AG, he will remain a trustee of the UK charity primarily funded by The
Camellia Foundation and as a nominee of The Camellia Foundation on the
Camellia Board.

 

Stephen Buckland, a nominee of The Camellia Foundation on the Camellia Board,
has been appointed a director of the Camellia Private Trust Company (the
trustee of The Camellia Foundation (Bermuda)) and director of Camellia Holding
AG.

 

The Board will also in due course appoint an additional independent
Non-executive Director to increase the number to three, one of whom will be
appointed as Senior Independent Director.

 

 

Additional Information

 

In accordance with the AIM Rules, the following information required to be
disclosed in relation to the director is set out below. Other than this
information, there is no further information required to be disclosed under
paragraph (g) of Schedule Two of the AIM Rules.

 

 Full name:                                       Kenneth Byron Coombs (known as "Byron Coombs")
 Age:                                             63
 Current beneficial shareholding in the Company:  None
 Current directorships:                           Julius Baer International Limited
 Previous directorships within the last 5 years:  FINHUMF

 

 

 

 

Enquiries

Camellia
Plc
01622 746655

Malcolm Perkins, Chairman & Interim CEO

Amarpal Takk, Group General Counsel & Company Secretary

 

Panmure Gordon
 
020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

Maitland/AMO
 
07785 292617

PR

William Clutterbuck
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGPUQUMUPWGUQ